Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 2014. The report serves as a notification of transactions involving a Person Discharging Managerial Responsibility (PDMR) under the GlaxoSmithKline US Deferred Performance Share Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document is limited to a specific transaction notification and does not contain financial statements or performance metrics.
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The only reported change is an increase in the American Depositary Shares (ADSs) held by Mr. D E Troy.
Guidance, Outlook, and Risks
The filing contains no management commentary, guidance, outlook, risks, contingencies, or unusual items. It strictly details a transaction where Mr. D E Troy acquired 371,689 ADSs at a price of $52.55 per ADS following the re-investment of the dividend paid on April 10, 2014.
Key Facts for Investor Verification
- Transaction Date: April 16, 2014 (Notification date).
- Individual: Mr. D E Troy (Person Discharging Managerial Responsibility).
- Shares Acquired: 371,689 ADSs.
- Price per ADS: $52.55.
- Transaction Type: Re-investment of dividend paid on April 10, 2014.
- Regulatory Basis: Disclosure and Transparency Rule 3.1.4R(1)(a).